<!DOCTYPE html>
<html lang="zh-CN">
  <head>
    <meta charset="utf-8">
    <meta name="robots" content="noindex,nofollow">
    <!-- 渲染优化 -->
    <meta name="renderer" content="webkit">
    <meta name="force-rendering" content="webkit">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="HandheldFriendly" content="True" >
    <meta name="apple-mobile-web-app-capable" content="yes">
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">

    <title>Yanjun Tan</title>
    
      <meta name="keywords" content="Resume,Hexo,Resume Theme">
    
    
      <meta name="description" content="Undergraduate student:&nbsp;Clinical Medicine (pediatrics)<br> Soochow University, China">
    

    <!-- import meta -->
    
    <!-- import link -->
    

    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5.12.1/css/all.min.css">
    
      
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fancyapps/fancybox@3.5/dist/jquery.fancybox.min.css">

    
    <!-- style.css -->
    
      
<link rel="stylesheet" href="/css/page.css">

    
  <meta name="generator" content="Hexo 5.4.0"></head>
  <body class="docs">
    <div id="mobile-bar">
      <a class="menu-button fas fa-bars"></a>
      <h2 class="nav-title">Yanjun Tan</h2>
      
    </div>
    
<script src="https://cdn.jsdelivr.net/npm/vue@2.6/dist/vue.min.js"></script>

    <script>
      Vue.config.productionTip = false
      window.PAGE_TYPE = "resume"
    </script>

    <div id="main" class="fix-sidebar">
      <div class="sidebar">
  <div class="sidebar-inner">
    <header class='header'>
      <h2>Yanjun Tan</h2>
      
      <div class='meta'>
        
          <p><a target="_blank" rel="noopener" href='https://www.researchgate.net/profile/Yanjun-Tan-2'>
            <i class="fab fa-researchgate fa-fw"></i>&nbsp;researchgate.net</a></p>
        
          <p><a target="_blank" rel="noopener" href="mail to：tangenttam@gmail.com">
            <i class="fas fa-envelope fa-fw"></i>&nbsp;tangenttam@gmail.com</a></p>
        
          <p><a target="_blank" rel="noopener" href='https://scholar.google.com/citations?user=_3qg7ygAAAAJ&hl=zh-CN'>
            <i class="fab fa-google fa-fw"></i>&nbsp;google</a></p>
        
      </div>
    <hr><br>
    </header>
    <div class="list">
      <ul class="menu-root">
        
          <li>
            <a href="/zh-cn/index.html" class="sidebar-link current"></a>
          </li>
        
          <li>
            <a href="/README.html" class="sidebar-link current"></a>
          </li>
        
          <li>
            <a href="/index.html" class="sidebar-link current"></a>
          </li>
        
      </ul>
    </div>
    
  </div>
</div>

<div class="content with-sidebar">
  <div class='resume-header'>
    
      <div class='avatar'><img no-lazy src='images/avater.png'/></div>
    
    <h1 class='resume-title'>Yanjun Tan</h1>
    <p class='description'>Undergraduate student:&nbsp;Clinical Medicine (pediatrics)<br> Soochow University, China</p>
    
  </div>
  <!-- 
<center>
<a href='/'>English</a> | <a href='/zh-cn/'>简体中文</a>
</center>
 -->


<h2 id="Biography"><a href="#Biography" class="headerlink" title=" Biography"></a><i ></i> Biography</h2><p>I am a <strong>determined</strong>, persevering and a <strong>hardworking</strong> cooperator with a divergent thinking mode and a <strong>strong memory.</strong> </p>
<p>My present goal is to seek for an available Ph.D position in some groundbreaking immunology programs. </p>
<p>My ultimate goal is to make lab achievements really benefit the clinical patients. </p>
<hr>
<b>
What I can bring to your lab?</b>
<ul>
<li><u><b>A handful and scrupulous companion:</b></u>&nbsp;good at doing experiments with molecular, cellular and histological approaches. Trump card  in animal experiments ( skillful in building various animal disease models)</li>
<li><u><b>A sharp thinker:</b></u>&nbsp;;good at observing the unnoticed experiment phenomenon and raising possible hypotheses </li>
<li><u><b>A curious science lover:</b></u>&nbsp;always following the cutting-edge discovery and willing to testify the bold assumption</li>
<li><u><b>A ready-to-help cooperator: </b></u>&nbsp;offering the kindness at any time </li>
<li><u><b>A multidisciplinary problem solver: </b> </u>&nbsp;multidisciplinary background including clinical medicine, biomaterials and immunology allows me to solve scientific problems in multifaceted perspectives</li>
</ul>





<h2 id="Education"><a href="#Education" class="headerlink" title=" Education"></a><i  ></i> Education</h2><p><b>Soochow University, Suzhou, China</b>   <span style="float:right"> <i>Sept.2017-June.2022</i></span><br>Bachelor of Clinical Medicine (Pediatrics)     <span style="float:right">  [five-year undergraduate program]</span><br><b>GPA:</b>3.8/4.0 &nbsp; &nbsp; &nbsp; &nbsp; <b>Ranking:</b>1/51</p>
<p><span><b>Standard Test</b><br>TOEFL:110(R30+L27+S25+W28)      <span style="float:right"> GRE:322(V156+Q165+AW4.0)</span></p>
<p><span><b>Awards &amp; Honors</b><br><br>Special Prize for Excellent Study <span style="float:right">2017-2019</span><br><br>Ideal Ophthalmology Scholarship<span style="float:right">2018-2019</span><br><br>First Prize for Excellent Study  <span style="float:right">2019-2020</span><br><br>Special Prize for Innovation and research<span style="float:right">2019-2020</span><br><br>People’s Comprehensive Scholarship   <span style="float:right">2019-2020</span><br><br>Merit Student      <span style="float:right">2019-2020</span><br></span></p>
<h2 id="Academic-Interests"><a href="#Academic-Interests" class="headerlink" title=" Academic Interests"></a><i ></i> Academic Interests</h2><p><span><b>Cancer Immunolgy<br></b></p>
<ol>
<li>Glycolysis in the TME</li>
<li>Transformation of Th17 cells in TME</li>
<li> Activation of NF-kB pathway in the TME</li>
<li>Type-Ⅱ immunity against cancer development</li>
<li>Immune checkpoint in the tumor microenvironment (TME)</li>
<li>Possibility of innate immune cells, such as neutrophils and NK cells, to specifically kill against cancer cells </li>
</ol>

<p><span><b>Mucosal Immunology<br></b></p>
<ol>
<li>Mechanisms to ensure robust tolerance induction in the mucosae</li>
<li>The cues for controlling elaborate balance between tolerance and resistance pathways that operate in the intestinal tissue</li>
<li> Mechanisms by which neuro-immune interactions in the intestine respond to local and distal perturbations</li>
<li>Mechanisms by which intestine stimulation influences systemic immune responses</li>
</ol>

<p><span><b>Neuroimmunology<br></b></p>
<ol>
<li>Therapy target of meningeal lymphatics in brain tumor</li>
<li>Function of T cells in cognitive disorders</li>
<li> Function of cytokines in memory formation and retrieval</li>
<li>Harness the immune system to cure neurodegenerative diseases</li>
</ol>





<h2 id="Research-Experience"><a href="#Research-Experience" class="headerlink" title="Research Experience"></a><i ></i>Research Experience</h2><p>I have <strong>four years</strong> of research experience. I took part in projects stretching across stem cell regeneration, occurrence of cancer and immunotherapy. Luckily, immunology seizes me. Through immunology, I found the omnipotent key to open the door of science.</p>
<p>My major interdisciplinary projects revolved around <u><strong>improving immunotherapy via nanomaterials.</strong> </u></p>
<p>Simply put, I observed the <u><strong>unnoticed immunological phenomenon carefully and crosslinked the cutting-edge treatments to refine the immunotherapy</strong></u></p>
<h3 id="Lab-of-Advanced-Biomaterials-and-Nanomedicine"><a href="#Lab-of-Advanced-Biomaterials-and-Nanomedicine" class="headerlink" title="Lab of Advanced Biomaterials and Nanomedicine"></a>Lab of Advanced Biomaterials and Nanomedicine</h3><p><b>Ⅰ.Mechanism-Informed Combinatorial Immunotherapy  <br></b><br><a target="_blank" rel="noopener" href="https://scholar.google.com/citations?user=AIJbgl0AAAAJ&hl=zh-CN">Prof. Zhuang Liu</a> &amp; <a target="_blank" rel="noopener" href="https://scholar.google.com/citations?user=HYo3mysAAAAJ&hl=zh-CN">Qian Chen </a><span style="float:right">2019-2022</span></p>
<ul>
<li>
<b>Refined immunotherapy for tumor radiofrequency ablation (RFA) via temperature sensitive hydrogel (thermogel)<br></b>Project Host<span style="float:right"><i>June. 2020-Aug. 2021</i></span>
<p  align="left">
In this research, a convenient local administration strategy by blocking rho-associated kinases <b>(ROCK)</b> is applied to amplify the immune responses triggered by  <b>RFA </b> via promoting the phagocytosis capacity of <b>DC</b>s. Briefly, ROCK inhibitors were successfully dispersed in amphiphilic copolymer poly(D,L-lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(D,L-lactideco-glycolide) <b>(PLGA-PEG-PLGA)</b> aqueous solution, which is a sol at room temperature and forms hydrogel quickly at body temperature, successfully prolonging the retention of ROCK inhibitors after just one single injection. Interestingly, in the melanoma tumor model, the generated tumor fragments after RFA treatment were swallowed by DCs and underwent reinforced <b>antigen presentation process </b>with the help of released  ROCK inhibitors, further effectively activating <b>T cell-mediated anti-tumor immune responses</b> and significantly improving the therapeutic efficiency of RFA. Moreover, such strategy remarkably prolongs the survival of mice after RFA treatment, showing great potential for clinical translation as an improvement strategy for RFA.</p>

<br>
<b>Achieved Goals</b>
<ul>
<li>Increased maturation of DCs</li>
<li>Enhanced phagocytosis of DCs</li>
<li>Activation of T cell-mediated anti-tumor immune responses</li>
</ul>
<br>
</li>

<li>
<b>Self-assembled anti-inflammatory hydrogel for enhanced αPDL1 immune checkpoint therapy<br></b>Project Cooperator <span style="float:right"><i>Apr.2019-May.2020</i></span>
<p  align="left">
Here, an <b>anti-inflammatory nanofiber hydrogel</b> self-assembled by betamethasone <b>(steroid drug)</b> is developed for local delivery of anti-programmed cell death protein ligand 1 <b>(αPDL1)</b>. On the one hand, this carrier-free system based on steroid drugs can reprogram the pro-tumoral immunosuppressive tumor microenvironment <b>(TME)</b> to anti-tumoral TME via inhibiting <b>NF-κB signal pathway</b>; on the other hand, it would serve as a reservoir for sustained release of αPDL1 so as to synergistically boost the immune system. By local injection of such αPDL1 loaded hydrogel, therapeutic effects were observed in inhibiting both local tumors and abscopal tumors without any treatment. This work presents a unique hydrogel-based delivery system using clinically approved drugs, showing promise in improving the objective response rate of immune checkpoint therapy <b>(ICB)</b> and minimizing its systemic toxicity.
</p>
<!-- <table>
<tr>
 <td ><center><img src=images/lab1.png ><br><font size="2">1.Self-assembled betamethasone hydrogel(BetP-Gel)</font>
 </center></td>
<td ><center><img src=images/lab2.png   ><br><font size="2">2.TEM image of BetP- hydrogel</font>
</center></td>
</tr>
<tr>
<td><center><img src=images/lab3.png   ><br><font size="2">3.Gelation mechanism</font>
</center></td>
<td ><center><img src=images/lab4.png   ><br><font size="2">4.Therapy Scheme</font>
</center> </td>
</tr>
</table> -->

<center>
<table>
 <td ><center><img src=images/lab1.png  height="150" ><br><font size="2"> TEM image of BetP-Gel</font></center>
</td>
 <td ><center><img src=images/lab2.png height="150"><br><font size="2">Self-assembled BetP-Gel</center>
</font>
</td>
 <td ><center><img src=images/lab3.png height="150"><br><font size="2">Gelation mechanism</center>
</font>
</td>
</table>
</center>

<center>
<table>
 <td ><center><img src=images/lab4.png  height="300"><br><font size="2">Therapy Scheme</font></center>
</td>
</table>
</center>


<br>
<b>Achieved Goals</b>
<ul>
<li>Downregulating inflammation</li>
<li>Activation of T cell mediated anti-tumor immune responses
</li>
</ul>
<br>
</li>

<li>
<b>Mechanobiological and immune regulative hydrogel (PNIPAm-P) for wound closure<br></b>Project Cooperator <span style="float:right"><i> Oct.2020-Mar.2021</i></span>
<p  align="left">
Here, a mechanically active adhesive and immune regulative dressing is developed, mainly consisting of <b>temperature-sensitive hydrogel </b>[poly(N-isopropylacrylamide) PNIPAm] with semi-interpenetrating network structure. This hydrogel could strongly adhere to and actively contract the wound. More interestingly, the interspersed [poly(methacrylic acid)PMAA] could further promote wound healing via increasing the formation of new blood vessels and modulating inflammatory responses. In vivo mouse and porcine wound models validate the accelerated wound healing enabled by <b>active contraction</b> and <b>modulated inflammatory responses</b>. This mechanobiological and immune regulative dressing may provide a new avenue for wound management.</p>
<center>
<table>
 <td ><center><img src=images/lab5.png ><br><font size="2">Gelation Mechanism</font></center>
</td>
</table>
</center>

<br>
<b>Achieved Goals</b>
<ul>
<li>Strong adhesion</li>
<li>Mechanical contraction</li>
<li>Inflammatory modulation
</li>
</ul>
<br>
</li>

<li>
<b>Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy<br></b>Project Cooperator <span style="float:right"><i>Oct. 2020-Mar. 2021</i></span>
<p   align="left">
Here, the reactive oxygen species (ROS)-responsive hydrogel, covalently cross-linked by phenylboronic acid-modified 7-ethyl-10-hydroxy<b>camptothecin</b> (SN38- SA−BA) with poly(vinyl alcohol) (PVA), is fabricated for topical delivery of anti-programmed cell death protein ligand 1 antibodies <b>(aPDL1)</b>. In the presence of endogenous <b>ROS</b>, SN38-SA−BA will be oxidized and hydrolyzed, leading to the degradation of hydrogel and the release of initial free SN38 and encapsulated aPDL1. It is demonstrated that SN38 could elicit specific immune responses by triggering <b>immunogenic cell death (ICD)</b> of cancer cells, a distinct cell death pathway featured with the release of immunostimulatory damage-associated molecular patterns <b>(DAMPs)</b>. Meanwhile, the released aPDL1 could bind to programmed cell death protein ligand 1 (PDL1) expressed on cancer cells to <b>augment antitumor T cell</b> responses. Thus, the ROS-responsive prodrug hydrogel loaded with aPDL1 could induce effective innate and adaptive antitumor immune responses after local injection, significantly inhibiting or even eliminating those tumors.</p>

<center>
<table>
 <td ><center><img src=images/lab6.png  height="300" ><br><font size="2">Gelation Mechanism</font></center>
</td>
 <td ><center><img src=images/lab7.png  height="300" ><br><font size="2">ROS-responsive Mechanism</center>
</font>
</td>
</table>
</center>

<center>
<table>
 <td ><center><img src=images/lab8.png ><br><font size="2">Therapy Scheme</font></center>
</td>
</table>
</center>

<br>
<b>Achieved Goals</b>
<ul>
<li>ROS-responsive hydrolysis</li>
<li>ICD induced by SN38</li>
<li>Enhanced antitumor T cell responses

</li>
</ul>
<br>
</li>

</ul>

<h3 id="Lab-of-Biochemistry-and-Molecular-Biology"><a href="#Lab-of-Biochemistry-and-Molecular-Biology" class="headerlink" title="Lab of Biochemistry and Molecular Biology"></a>Lab of Biochemistry and Molecular Biology</h3><p><b>Ⅱ. Occurrence of Cancer  <br></b><br><a target="_blank" rel="noopener" href="https://www.researchgate.net/scientific-contributions/Minghua-Wang-38211916">Prof. Minghua Wang</a>  <span style="float:right">2018-2019</span></p>
<ul>
<li>
<b>Mechanism of the methylation-regulated gene TLX2 (a transcriptional factor) in the occurrence of esophageal tumor<br></b>Project Host<span style="float:right"><i>Mar. 2018-Feb.2019</i></span>

<p>After searching in the TCGA database, we found that TLX2 (a transcriptional factor) methylation upregulated greatly in esophageal tumor. According to the previous literature, my supervisor hypothesized that the methylated TLX2 promoted the occurrence of esophageal tumor.</p>
</li>
<li>Test the expression efficiency of TLX2 on different flag plasmid carriers and select p3×flag-TLX2 plasmid carrier to track down the protein interacting with TLX2
</li>
<li>Testify that TLX2 can suppress the occurrence of esophageal tumor
</li>
</ul>

<h3 id="Lab-of-Hematology"><a href="#Lab-of-Hematology" class="headerlink" title="Lab of Hematology"></a>Lab of Hematology</h3><p><b>Ⅲ. Stem Cell Generation  <br></b><br><a target="_blank" rel="noopener" href="https://www.researchgate.net/scientific-contributions/Jianrong-Wang-76163729">Prof. Jianrong Wang </a>  <span style="float:right">Oct.2017-Feb.2018</span></p>
<ul>

<li>Conquer basic molecular approaches such as polymerase chain reaction (PCR), quantitative-PCR and western blot (WB)
</li>
<li>Learn how to operate stem cell transplantation on mice
</li>
</ul>

<h2 id="Publications"><a href="#Publications" class="headerlink" title=" Publications"></a><i ></i> Publications</h2><p><font face=Times New Roman><i><br>Chen, M#.; <b>Tan, Y#</b>.; et al.; Liu, Z.; Chen, Q., “Injectable Immunotherapeutic Thermogel for Enhanced Immunotherapy Post Tumor Radiofrequency Ablation”. Small 2021 [Accepted]<br><br><br>Chen M#, <b>Tan Y</b>, Dong Z, Lu J, Han X, Jin Q, Zhu W, Shen J, Cheng L, Liu Z*, Chen Q*.(2020) Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration. Nano Lett. 2020 Sep 9;20(9):6763-6773. doi: 10.1021/acs.nanolett.0c02684.|<a href="pdf/1.pdf">PDF</a><br><br><br>Gong Y#, Chen M#, <b>Tan Y</b>, Shen J, Jin Q, Deng W, Sun J, Wang C, Liu Z, Chen Q*.(2020) Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy. ACS Appl Mater Interfaces. 2020 Nov 11;12(45):50248-50259. doi: 10.1021/acsami.0c13943.|<a href="pdf/2.pdf">PDF</a><br><br><br>Hu J#, Wei T#, Zhao H, Chen M, <b>Tan Y</b>, Ji Z, Jin Q, Shen J, Han Y, Yang N, Chen L, Xiao Z, Zhang H, Liu Z, Chen Q*.(2021) Matter 2021 July 28; 4, (9), 2985-3000.doi:10.1016/j.matt.2021.06.044.<br>|<a href="pdf/3.pdf">PDF</a></p>
<p></i></font></p>
<h2 id="CV"><a href="#CV" class="headerlink" title=" CV"></a><i ></i> CV</h2><center>
<table>
<img src=images/CV1.jpg >


<img src=images/CV2.jpg>
</center>
<!-- <i class="fas fa-envelope fa-fw"></i> your email -->
<!-- <i class="fas fa-phone-alt fa-fw"></i> 1xxxxxxxxxx -->




  
</div>

    </div>
    
      
<script src="https://cdn.jsdelivr.net/gh/xaoxuu/hexo-theme-resume@1.0.0/source/js/smooth-scroll.min.js"></script>

    

    
      <footer id="footer">
        <p><p><a href="/">Copyright © 2017-2020 XXX</a></p>
</p>
      </footer>
    

    
<script src="https://cdn.jsdelivr.net/npm/jquery@3.5/dist/jquery.min.js"></script>

    
      
<script src="https://cdn.jsdelivr.net/gh/xaoxuu/hexo-theme-resume@1.0.0/source/js/common.js"></script>

    
    
      
<script src="https://cdn.jsdelivr.net/gh/xaoxuu/hexo-theme-resume@1.0.0/source/js/css.escape.js"></script>

    

    
      <script src="https://cdn.jsdelivr.net/gh/fancyapps/fancybox@3.5/dist/jquery.fancybox.min.js"></script>
      <script>
        let LAZY_LOAD_IMAGE = "";
        $("body").find("fancybox").find("img").each(function () {
            var element = document.createElement("a");
            $(element).attr("data-fancybox", "gallery");
            $(element).attr("href", $(this).attr("src"));
             if (LAZY_LOAD_IMAGE) {
               $(element).attr("href", $(this).attr("data-original"));
             }
            $(this).wrap(element);
        });
      </script>
    

  </body>
</html>
